(R)-1,4-bis(((9H-fluoren-9-yl)methoxy)carbonyl)piperazine-2-carboxylic acid

Catalog No. :
ACIMBG843
CAS No. :
1217813-63-2
Molecular Formula :
C35H30N2O6
Molecular Weight :
574.63

IUPAC Name:(R)-1,4-bis(((9H-fluoren-9-yl)methoxy)carbonyl)piperazine-2-carboxylic acid

(R)-1,4-bis(((9H-fluoren-9-yl)methoxy)carbonyl)piperazine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$94.00Login to see priceIn stockInquiry
250mg95%$188.00Login to see priceIn stockInquiry
500mg95%$282.00Login to see priceIn stockInquiry
1g95%$469.00Login to see priceIn stockInquiry
5g95%$1406.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1,4-bis(((9H-fluoren-9-yl)methoxy)carbonyl)piperazine-2-carboxylic acid
IUPAC Name(R)-1,4-bis(((9H-fluoren-9-yl)methoxy)carbonyl)piperazine-2-carboxylic acid
Molecular FormulaC35H30N2O6
Molecular Weight574.63
SMILESO=C(O)[C@H]1CN(C(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)CCN1C(=O)OCC1C2=CC=CC=C2C2=C1C=CC=C2
InChI KeyJGSIWGDUBFOXHQ-JGCGQSQUSA-N
Synonym(2R)-1,4-bis(9H-fluoren-9-ylmethoxycarbonyl)piperazine-2-carboxylic acid;1,2,4-Piperazinetricarboxylic acid, 1,4-bis(9H-fluoren-9-ylmethyl) ester, (2R)-
CAS No.1217813-63-2

Synthetic Route by SureRoute

1. ACIMBG843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDRCI164 route compound structure diagram
    ACDRCI164747393-31-3 In Stock
  4. Then
  5. ACIMBG843 route product structure diagram
    ACIMBG8431217813-63-2 In Stock
Inquiry

2. ACIMBG843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMBG843 route product structure diagram
    ACIMBG8431217813-63-2 In Stock
Inquiry

Comments (0)